Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $63.84 ($418K) on 2012-05-15, disclosed to the SEC on 2012-05-16.
Scheduled sale ($418k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.84 | 2,100 | $134K | 32.1% |
| 2 | $64.30 | 3,700 | $238K | 56.9% |
| 3 | $65.50 | 700 | $46K | 11.0% |
| Total | $64.28 avg | 6,500 | $418K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |